We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

132 hedge funds and large institutions have $225M invested in Enanta Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 45 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 25

0% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 45

0.4% less ownership

Funds ownership: 96.05% → 95.65% (-0.4%)

1% less funds holding

Funds holding: 133 → 132 (-1)

47% less call options, than puts

Call options by funds: $9K | Put options by funds: $17K

49% less capital invested

Capital invested by funds: $438M → $225M (-$213M)

Holders
132
Holders Change
-1
Holders Change %
-0.75%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
45
Reduced
45
Closed
25
Calls
$9K
Puts
$17K
Net Calls
-$8K
Net Calls Change
-$14K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$12.7M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$8.75M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$7.22M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.97M
5
Morgan Stanley
Morgan Stanley
New York
+$4.14M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$28.2M
2
State Street
State Street
Massachusetts
-$17.2M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$4.01M
4
Norges Bank
Norges Bank
Norway
-$3.22M
5
Principal Financial Group
Principal Financial Group
Iowa
-$2.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$1.61M +$2.16M +134,360 +1,382%
AQR Capital Management
27
AQR Capital Management
Connecticut
$1.54M +$1.91M +118,320 +608%
TI
28
Trexquant Investment
Connecticut
$1.48M +$2.14M +132,561 New
Two Sigma Advisers
29
Two Sigma Advisers
New York
$1.48M +$1.71M +105,900 +400%
Walleye Capital
30
Walleye Capital
New York
$1.33M +$1.49M +92,410 +343%
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
$1.27M +$1.1M +68,076 +149%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.21M -$932K -57,838 -35%
HF
33
HRT Financial
New York
$1.15M +$1.65M +102,698 New
EAM
34
Erste Asset Management
Austria
$1.06M – – –
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$989K +$1.23M +76,127 +613%
Marshall Wace
36
Marshall Wace
United Kingdom
$836K +$1.2M +74,810 New
CSS
37
Cubist Systematic Strategies
Connecticut
$766K -$514K -31,942 -32%
PP
38
PDT Partners
New York
$752K +$639K +39,699 +144%
Janney Montgomery Scott
39
Janney Montgomery Scott
Pennsylvania
$698K +$1.01M +62,452 New
JF
40
Jump Financial
Illinois
$633K +$267K +16,608 +41%
N
41
Nuveen
North Carolina
$620K -$9.58K -595 -1%
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$619K +$138K +8,596 +18%
SEI Investments
43
SEI Investments
Pennsylvania
$535K +$771K +47,879 New
Ameriprise
44
Ameriprise
Minnesota
$497K -$1.12M -69,424 -61%
Swiss National Bank
45
Swiss National Bank
Switzerland
$483K – – –
Balyasny Asset Management
46
Balyasny Asset Management
Illinois
$470K +$677K +42,064 New
Verition Fund Management
47
Verition Fund Management
Connecticut
$436K +$469K +29,113 +292%
Fidelity Investments
48
Fidelity Investments
Massachusetts
$389K -$1.7M -105,399 -75%
PGA
49
Portland Global Advisors
Maine
$382K – – –
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$363K -$520K -32,264 -50%
1
2
3 4 5

ENTA Hedge Fund Activity: Q3 2023 in Review

132 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q3 2023, worth a combined $225M — down 49% from $438M a quarter earlier.

Fund positioning in ENTA was balanced in Q3 2023: 25 funds opened new positions, 25 closed out, 45 added to existing stakes and 45 trimmed.

The largest buyer was Millennium Management, adding an estimated $12.7M. The largest seller was BlackRock, cutting an estimated $28.2M.

  • 132 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q3 2023, down from 133 in Q2 2023.
  • Funds reported $225M of Enanta Pharmaceuticals stock for Q3 2023, down 49% quarter-over-quarter.
  • 25 funds opened new Enanta Pharmaceuticals positions in Q3 2023 and 25 closed out, a net change of 0 holders.
  • The largest Enanta Pharmaceuticals buyer in Q3 2023 was Millennium Management, an estimated $12.7M added.
  • The largest Enanta Pharmaceuticals seller in Q3 2023 was BlackRock, an estimated $28.2M sold.

Based on aggregated 13F filings for Q3 2023.